Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
about
Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and review of the literature.Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patientsPrognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohortAblative Therapies in Metastatic Breast Cancer: A Systematic Review.Integrin-mediated traction force enhances paxillin molecular associations and adhesion dynamics that increase the invasiveness of tumor cells into a three-dimensional extracellular matrix.Trastuzumab and survival of patients with metastatic breast cancer.Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post-metastatic survival: 35-year results from the Munich Cancer Registry.Prognostic impact of metastatic pattern in stage IV breast cancer at initial diagnosis.Site of metastasis and breast cancer mortality: a Danish nationwide registry-based cohort study.Development and validation of a nomogram predicting the overall survival of stage IV breast cancer patients.Neutrophil-Derived Interleukin 16 in Premetastatic Lungs Promotes Breast Tumor Cell Seeding.Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2- advanced breast cancer in the randomized MONALEESA-2 trial.Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?Response to "Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?"The Difference in Prognostic Outcomes Between De Novo Stage IV and Recurrent Metastatic Patients with Hormone Receptor-positive, HER2-negative Breast Cancer.New Strategies in Metastatic Hormone Receptor-Positive Breast Cancer: Searching for Biomarkers to Tailor Endocrine and Other Targeted Therapies.Practical consensus recommendations regarding the management of HER2 neu positive metastatic breast cancer.Metastatic and triple-negative breast cancer: challenges and treatment options
P2860
Q30992939-38372743-4020-4485-B99B-1EED1F4403DBQ36069770-AB2B65F1-9BB1-42A0-A1C1-57DFB2EA7ED3Q36070763-A4BED185-3212-4F5E-8CB3-7F35908C9AC6Q36344204-5FF6C310-22EC-4CD2-99E1-9D78349DF3FCQ38851702-A5EBD184-D41E-4ED0-9472-6A01BA60AE13Q40159320-C9EE4623-CB88-4BEF-BFA9-E20345925D27Q40233516-5F54A44C-035A-42E1-A3AD-28108FAF2EC5Q40424679-6EE17892-45FA-44A4-99CA-602DACDE0750Q40549693-A188BDA9-51C8-4195-ABE5-2DA9F542F349Q47103495-C7425CC3-9C52-4354-98D9-39A2C02F03BCQ47159534-59F6507E-BB03-48F5-94C9-AFEF79F3981EQ48257534-20AF5A1E-4807-443C-844F-A4AFF2814F4AQ48349915-14A24884-8265-4397-9F94-90DDEE024FFAQ51175392-6B057047-E57F-4FD0-92F4-36EA65EFE9E1Q52687764-779D2FFB-4AD8-418E-B77C-E47E125878A0Q52942118-B8B6BF73-94D7-442C-88B1-767BC279AEA5Q54956987-E129E30C-31D2-413A-90C7-380D6EF11079Q57105258-8260E516-9D16-4A63-9105-F6FE0626E476
P2860
Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognosis of metastatic breast ...... rent metastatic breast cancer?
@ast
Prognosis of metastatic breast ...... rent metastatic breast cancer?
@en
type
label
Prognosis of metastatic breast ...... rent metastatic breast cancer?
@ast
Prognosis of metastatic breast ...... rent metastatic breast cancer?
@en
prefLabel
Prognosis of metastatic breast ...... rent metastatic breast cancer?
@ast
Prognosis of metastatic breast ...... rent metastatic breast cancer?
@en
P2093
P2860
P356
P1476
Prognosis of metastatic breast ...... rent metastatic breast cancer?
@en
P2093
A J van de Wouw
D J A Lobbezoo
F P J Peters
F van den Berkmortel
J M G H van Riel
M W Dercksen
N A J B Peters
P G M Peer
R J W van Kampen
P2860
P2888
P304
P356
10.1038/BJC.2015.127
P407
P577
2015-04-16T00:00:00Z